Notice of Intent to award a sole source.pdf
PDF 116 KB Posted
- Solicitation number
- REQT-OMAS-PS-2026-00010
About this file
This is a Notice of Intent to Award a Sole Source contract. The Department of Health and Human Services (DHHS), Office of Mission Acquisition Solutions (OMAS), on behalf of the Office of Medicare Hearings and Appeals (OMHA), intends to award a noncompetitive contract to Elsevier Inc., located at 230 Park Avenue, Floor 8, New York, NY 10169, for 32 Clinical Pharmacology Compendia Licenses Subscriptions. The Clinical Pharmacology Compendium provides access to drug information on more than 50,000 medication products, including FDA-approved prescription medicines, over-the-counter medicines, dietary supplements, and investigational drug agents, with comprehensive coverage of drugs and biologics used in cancer treatment and management.
The sole source justification under FAR 13.106-1(b) is based on Medicare Part B regulations establishing a national drug compendium for determining anti-cancer drug therapy coverage. Elsevier's Clinical Pharmacology compendium is the exclusively approved compendium for this purpose, and Administrative Law Judges and attorneys require access to make determinations on anti-cancer drug coverage. The period of performance consists of a 12-month base period and four optional 12-month renewal periods. All responsible sources may submit responses demonstrating clear and convincing evidence of capability to fulfill the requirement by June 23, 2026, at 12:00 p.m. Eastern Time to azeb.mengistu@hhs.gov, referencing announcement number REQT-OMAS-PS-2026-00010. Respondents must include DUNS Number, Unique Entity Identifier, Taxpayer Identification Number, business size certification, and maintain active SAM registration.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOTICE OF INTENT TO AWARD A SOLE SOURCE
Introduction
The Department of Health and Human Services (DHHS), Office of Mission Acquisition
Solutions (OMAS), on behalf of the Office of Medicare Hearings and Appeals (OMHA), intends to award Clinical Pharmacology Compendia Licenses Subscription on a sole source basis.
Intent to Award
This notice announces the proposed acquisition as an intent to award a contract on a non-competitive basis to Elsevier Inc., located at 230 Park Avenue, Fl 8, New York, NY 10169.
Description of Requirement Description of Requirement : The purpose of this requirement is to secure a contractor to provide 32 Clinical Pharmacology Compendia Licenses Subscription.
The Contractor shall provide 32 licenses for access to their medical compendia. The Clinical
Pharmacology Compendium is widely recognized by health care professionals and corporations both nationally and internationally as a reliable, credible, authoritative, accurate, timely, and comprehensive drug information source. Clinical Pharmacology offers information on more than
50,000 medication products, including U.S. FDA-approved prescription medicines, over-the-counter medicines, a variety of dietary supplements, and investigational drug agents. The database includes a comprehensive listing of drugs and biologics used in the treatment and management of patients with cancer in the United States.
Required Capabilities
Required Capabilities: This procurement is being solicited from a single source under FAR
13.106-1(b) because, under regulations for Medicare Part B, a national drug compendium was established to assist in determining coverage for anti-cancer drug therapy. The Elsevier Clinical
Pharmacology compendium has been approved exclusively to this company and its listing.
Administrative Law Judges and attorneys require access to this compendium to make determinations on anti-cancer drug coverage.
Period of Performance
Period of Performance: OMHA requires twelve (12) months as a base period and four (4) twelve (12) month option periods for the Clinical Pharmacology Licenses Subscription.
Closing Statement
Closing Statement: This synopsis is NOT a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this synopsis must include clear and convincing evidence of the respondent's capability to fulfill the requirement. All responsible sources may submit a response, which, if timely received, will be considered by the agency. A determination by the Government not to compete this proposed contract based upon this notice is within the discretion of the Government.
Submission Instructions
All responses must be received by June 23, 2026, 12:00pm Eastern Time. Responses must be submitted electronically to Azeb Mengistu at azeb.mengistu@hhs.gov and must reference the announcement number # REQT-OMAS-PS-2026-00010.
FAX requests are not accepted. In addition, the Dun & Bradstreet Number (DUNS), Unique
Entity Identifier (UEI) Number, Taxpayer Identification Number (TIN), and certification of business size must be included in the response. All respondents must have an active registration in the System for Award Management (SAM) at www.sam.gov .
mailto:azeb.mengistu@hhs.gov http://www.sam.gov/
File details come from the government source that posted it. Updated .